相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
请参考说明书
- 亚型:
请参考说明书
- 形态:
液体
- 保存条件:
Aliquot and store at -20ºC
- 克隆性:
请参考说明书
- 标记物:
请参考说明书
- 适应物种:
human/mouse/rat等
- 宿主:
rabbit/mouse
- 应用范围:
ELISA,WB,IHC等
- 浓度:
请参考说明书
- 靶点:
请参考说明书
- 抗体英文名:
C1q antibody [3R9/2]
- 抗体名:
C1q antibody [3R9/2]
- 规格:
50μg
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验C1q Assay for the Detection of Complement Fixing Antibody to HLA Antigens
complement fixing from non-complement fixing antibody, the former of which are considered the most clinically relevant in the peri-transplant period. This chapter describes a novel solid phase C1q binding assay to distinguish HLA antibodies that can bind
Evaluation of Complement-Dependent Cytotoxicity Using ATP Measurement and C1q/C4b Binding
cytotoxicity (CDC), which induces cell lysis by a cascade of activation triggered by the binding of C1q subunits to the Fc regions of antibodies bound to the cell surface, is part of the mechanism of several antibody therapies. CDC can be modulated by either Fc
补体成分 C1(C1q/C1r/C1s) 补体成分:C1q 血清浓度(μg/ml):75 分子量(kDa):410 亚单位(链)及分子量(kDa):A:24各6条B:23各6条C:22各6条 生物学活性:识别IgG、IgMFc的补体结合点 补体成分:C1r 血清浓度(μg/ml):50 分子量(kDa):85
技术资料暂无技术资料 索取技术资料






![TGF beta Receptor I antibody [3A11]](https://img1.dxycdn.com/2023/0711/451/6106825198874858761-14.jpg!wh200)

